>
|
 |
ڻ, ɺ -
|
|
|
|
ɺ , 92% ȿ
|
|
|
|
|
|
|
۸ 漱 ڣ
ڻ簡 RE-MEDYTM RE-SONATETM ӻ ɺ ߴ.
ΰ ڻ簡 ɺ (DVT) (PE) Ⱓ ȿ RE-MEDYTM RE-SONATETM ӻ ױ۷ (New England Journal of Medicine) ƴٰ 26 .
̹ ǥ ӻ ڻ150mg 1 2ȸ ˷ ȯ ϴµ ־ Ȯ Ÿ.
ڻ ɺ ġ 濡 㰡 ʴ.
RE-SONATETM ӻ ڻ ɺ ̳ 92% ҽŲ Ÿ.
RE-MEDYTM ӻ ڻ ӻ ĸ 46% ߴ Ÿ ߿ ȿ ĸ ߴ.
ƿ 2012 ̱ȸ ǥ RE-SONATETM ӻ ߰ ڻ ɺ ȿ ġᰡ 1Ⱓ Ǵ ִ.
ɺ ϴ ȯ Ƽ 庴 ߿ ̾ ° ȯ ˷ ִ. ȯ , ֿ 6 鿡 75 ̻ ̱ 90 ̻ ϴ ˷ ִ.
ǥ ġḦ ȯڵ鿡 1 11% ϰ 10 Ŀ 40% ϴ . ̴ ȯ ġᰡ ̷ Ⱓ ִٴ ٽ ϴ ̴.
̿ ij ƸŽ б ǰ ס а "̹ ǥ RE-MEDY RE-SONATE ӻ ڻ簡 ɺ ʵ ϴµ ġ ɼ ϰ ִ" ߴ.
̾ "̹ ڻ ӻ ġϴ ϴ ӻ ĸ ϰ ϴ ȿ RE-COVER ӻ ġϴ ٽ ڻ ȿɰ Ȯϴ ̴" ٿ.
漱 (holicks88@mdtoday.co.kr)
<ǰ ̴ ѹα ǥ Ƿ, ǰ Ź , >
|
|
|
|